Sigilon Therapeutics Funding: $363M Raised, Growth (2023)

Sigilon Therapeutics funding overview

Sigilon Therapeutics is based in Cambridge, Massachusetts. Sigilon Therapeutics has raised $363M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in August 2023. The round record for Sigilon Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Eli Lilly and Company, BlackRock, Flagship Pioneering, Longevity Fund, Canada Pension Plan Investment Board. 5 distinct backers are named across the disclosed rounds.

Sigilon Therapeutics at a glance

Total raised: $363M
Latest round: Growth
Latest round date: August 2023
Headquarters: Cambridge, Massachusetts
Notable investors: Eli Lilly and Company, BlackRock, Flagship Pioneering, Longevity Fund, Canada Pension Plan Investment Board

Frequently asked about Sigilon Therapeutics funding

How much has Sigilon Therapeutics raised?: Sigilon Therapeutics has raised $363M in total disclosed funding across the rounds on record.
Who has invested in Sigilon Therapeutics?: Eli Lilly and Company, BlackRock, Flagship Pioneering, Longevity Fund, Canada Pension Plan Investment Board are named among the investors backing Sigilon Therapeutics.
What was the latest Sigilon Therapeutics funding round?: The most recent disclosed round is a Growth, announced in August 2023.
Where is Sigilon Therapeutics based?: Sigilon Therapeutics is based in Cambridge, Massachusetts.
When did Sigilon Therapeutics last raise?: The last disclosed Sigilon Therapeutics round closed in August 2023 at Growth.

Round data for Sigilon Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Sigilon Therapeutics Funding: $363M Raised, Growth (2023)

Sigilon Therapeutics funding overview

Sigilon Therapeutics at a glance

Frequently asked about Sigilon Therapeutics funding

Companies related to Sigilon Therapeutics (36)

Browse related funding lists (8)